Cargando…
Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
BACKGROUND: RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expressed in epithelial ovarian cancer (EOC). METHODS: Specifically, we sought candidat...
Autores principales: | Mosig, Rebecca A, Lin, Li, Senturk, Emir, Shah, Hardik, Huang, Fei, Schlosshauer, Peter, Cohen, Samantha, Fruscio, Robert, Marchini, Sergio, D'Incalci, Maurizio, Sachidanandam, Ravi, Dottino, Peter, Martignetti, John A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288733/ https://www.ncbi.nlm.nih.gov/pubmed/22272937 http://dx.doi.org/10.1186/1757-2215-5-4 |
Ejemplares similares
-
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
por: Mosig, Rebecca A, et al.
Publicado: (2012) -
Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer—Current Use and Future Opportunities
por: Paracchini, Lara, et al.
Publicado: (2021) -
Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer
por: Paracchini, Lara, et al.
Publicado: (2022) -
Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents
por: Colella, G, et al.
Publicado: (1999) -
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
por: Agnani, Deep, et al.
Publicado: (2011)